Polivy (polatuzumab vedotin)
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Polivy (polatuzumab vedotin), covering 2025-06-10 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma [Phase 2]